Richard Rychlik
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Rychlik
Richard Rychlik is recorded as CFO at Armata Pharmaceuticals, Inc. (ARMP). Armata Pharmaceuticals, Inc. reported in an 8-K filed September 26, 2024 that Richard Rychlik was terminated as Vice President, Corporate Controller, effective September 30, 2024. Armata Pharmaceuticals, Inc. reported in an 8-K filed September 20, 2023 that Richard Rychlik was appointed principal financial officer, effective September 15, 2023. The proxy statement of Armata Pharmaceuticals, Inc. reports total compensation of $360,407 for Richard Rychlik in fiscal 2024, including a base salary of $243,890. Disclosed compensation is on record for 2 fiscal years.
“On September 22, 2024, Armata Pharmaceuticals, Inc. (the "Company") reached an agreement with Richard Rychlik, the Company's Vice President, Corporate Controller, pursuant to which Mr. Rychlik's employment will conclude effective as of September 30, 2024.”
“On September 15, 2023, Richard Rychlik, Corporate Controller of Armata Pharmaceuticals, Inc. (“Armata” or the “Company”), was promoted to serve as Armata’s principal financial officer, replacing Julianne Averill of Danforth Advisors, LLC, who resigned as Chief Financial Officer on the same day.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-15–present
-
Armata Pharmaceuticals, Inc. (ARMP)
Proxy statement
Start not stated–2024-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Armata Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Deborah Birx CEO
- Deborah L. Birx CEO, Board Member
- Dr. Deborah Birx CEO, Board Member
- Richard J. Bastiani Chairman
- David House CFO
- Julianne Averill CFO
- Erin Butler Chief Accounting Officer
- Daniel Gilmer Board Member
- Dr. Daniel Gilmer Board Member
- Joseph M. Patti Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Armata Pharmaceuticals, Inc. (ARMP) | Former Vice President, Corporate Controller | $243,890 | $360,407 |
| 2023 | Armata Pharmaceuticals, Inc. (ARMP) | Former Vice President, Corporate Controller | $96,667 | $197,740 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.